Cortesi, Paolo Angelo, Damiano Paolicelli, Marco Capobianco, Paolo Cozzolino, and Lorenzo Giovanni Mantovani. “The Value and Sustainability of Ocrelizumab in Relapsing Multiple Sclerosis: A Cost-Effectiveness and Budget Impact Analysis”. Farmeconomia. Health economics and therapeutic pathways 20, no. 1 (July 10, 2019). Accessed July 23, 2025. https://provafe.seedstm.com/index.php/FE/article/view/1435.